Joint Statement on Clinical Trial Oversight in Canada
Description
Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB), recognize the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a medical device in treating, preventing, mitigating or diagnosing COVID-19.
Resources
| Name |
Format |
Description |
Link |
| Joint Statement on Clinical Trial Oversight in Canada |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/joint-statement-clinical-trial-oversight-canada.html |
| Joint Statement on Clinical Trial Oversight in Canada |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/declaration-commune-surveillance-essais-cliniques-canada.html |